Community pharmacists can play an active role in diagnostic testing by providing tests as well as pre- and post-test information to patients, FIP said in a Holding Statement released today. Diagnostic testing is one of the most important aspects in controlling a pandemic and it is both an ethical and a public health priority for access to testing be expanded, the federation says.

With this new statement, FIP urges governments and health authorities to support pharmacists who are appropriately trained to conduct testing to do so, so that quick, safe and professional mass testing is facilitated. In several countries pharmacists are already contributing to screening strategies through point-of-care tests but many more are available to provide these essential tests and look forward to joining efforts with other health professions using this strategy to bring the current pandemic under control, FIP says.

Read the full statement here.

The FIP SARS-CoV-2 Testing Working Group, assembled by the leadership of FIP, has produced guidance on tests and counselling to assist practising pharmacists in talking to people who have questions concerning SARS-CoV-2 tests.